X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9) 9
index medicus (8) 8
adult (7) 7
female (7) 7
male (7) 7
middle aged (6) 6
drug therapy (5) 5
hepacivirus - genetics (5) 5
hepatitis c, chronic - drug therapy (5) 5
simeprevir (5) 5
boceprevir (4) 4
drug therapy, combination (4) 4
genotype (4) 4
hepatitis (4) 4
hepatitis c (4) 4
hepatitis c virus (4) 4
internal medicine (4) 4
ribavirin (4) 4
telaprevir (4) 4
treatment outcome (4) 4
abridged index medicus (3) 3
adolescent (3) 3
double-blind method (3) 3
drug administration schedule (3) 3
gastroenterology & hepatology (3) 3
health aspects (3) 3
heterocyclic compounds, 3-ring - administration & dosage (3) 3
infections (3) 3
interferon (3) 3
interferon-alpha - administration & dosage (3) 3
medicine, general & internal (3) 3
once-daily tmc435 (3) 3
polyethylene glycols - administration & dosage (3) 3
recombinant proteins - administration & dosage (3) 3
ribavirin - administration & dosage (3) 3
sulfonamides - administration & dosage (3) 3
aged (2) 2
aids (2) 2
analysis (2) 2
antiretroviral therapy (2) 2
antiviral activity (2) 2
antiviral agents - administration & dosage (2) 2
antiviral agents - pharmacology (2) 2
antiviral agents - therapeutic use (2) 2
biological response modifiers (2) 2
chronic hepatitis-c (2) 2
clinical trials (2) 2
double-blind (2) 2
genetic aspects (2) 2
genotype & phenotype (2) 2
hepatitis-c (2) 2
heterocyclic compounds, 3-ring - adverse effects (2) 2
hiv infections - drug therapy (2) 2
in-vitro (2) 2
infectious diseases (2) 2
interferon alpha (2) 2
interferon-alpha - therapeutic use (2) 2
methods (2) 2
patient outcomes (2) 2
peginterferon (2) 2
pegylated interferon (2) 2
pharmacology & pharmacy (2) 2
phase-3 trial (2) 2
polyethylene glycols - therapeutic use (2) 2
protease inhibitor (2) 2
recombinant proteins - therapeutic use (2) 2
research (2) 2
ribavirin - therapeutic use (2) 2
risk factors (2) 2
rna, viral - blood (2) 2
sofosbuvir (2) 2
sulfonamides - adverse effects (2) 2
therapy (2) 2
viral nonstructural proteins - antagonists & inhibitors (2) 2
virological response (2) 2
virus-infection (2) 2
[ sdv.mhep ] life sciences [q-bio]/human health and pathology (1) 1
[sdv.mhep]life sciences [q-bio]/human health and pathology (1) 1
acid inhibitor (1) 1
acquired immune deficiency syndrome (1) 1
acquired immune deficiency syndrome--aids (1) 1
acquired immunodeficiency syndrome - immunology (1) 1
aids-related opportunistic infections - diagnostic imaging (1) 1
aids-related opportunistic infections - immunology (1) 1
alcohol (1) 1
alcohol-use (1) 1
alpha 2a (1) 1
alpha-2a (1) 1
anti-addiction drug therapy (1) 1
anti-hiv agents - adverse effects (1) 1
anti-hiv agents - therapeutic use (1) 1
antiretroviral therapy, highly active - adverse effects (1) 1
antiviral agents (1) 1
antiviral agents - chemistry (1) 1
antiviral therapy (1) 1
article (1) 1
association (1) 1
behavior (1) 1
biology and life sciences (1) 1
biopsy (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9956, pp. 1756 - 1765
Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9941, pp. 414 - 426
Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9941, pp. 403 - 413
Journal Article
Hepatology, ISSN 0270-9139, 12/2013, Volume 58, Issue 6, pp. 1918 - 1929
Journal Article
Journal Article
Journal Article
by Carrieri, Maria Patrizia and Marcellin, Fabienne and Fressard, Lisa and Préau, Marie and Sagaon-Teyssier, Luis and Suzan-Monti, Marie and Guagliardo, Valérie and Mora, Marion and Roux, Perrine and Dray-Spira, Rosemary and Spire, Bruno and Allègre, T and Mours, P and Riou, J.M and Sordage, M and Chennebault, J.M and Fialaire, P and Rabier, V and Froidure, M and Huguet, D and Leduc, D and Pichancourt, G and Wajsbrot, A and Bourdeaux, C and Foltzer, A and Hoen, B and Hustache-Mathieu, L and Abgrall, S and Barruet, R and Bouchaud, O and Chabrol, A and Mattioni, S and Mechai, F and Jeantils, V and Bernard, N and Bonnet, F and Hessamfar, M and Lacoste, D and Malvy, D and Mercié, P and Morlat, P and Paccalin, F and Pertusa, M.C and Pistone, T and Receveur, M.C and Vandenhende, M.A and Dupont, C and Freire Maresca, A and Leporrier, J and Rouveix, E and Dargere, S and De La Blanchardière, A and Martin, A and Noyon, V and Verdon, R and Rogeaux, O and Beytout, J and Gourdon, F and Laurichesse, H and Meier, F and Mortier, E and Simonpoli, A.M and Cordier, F and Delacroix, I and Garrait, V and Elharrar, B and Dominguez, S and Lascaux, A.S and Lelièvre, J.D and Levy, Y and Melica, G and Buisson, M and Piroth, L and Waldner, A and Gruat, N and Leprêtre, A and De Truchis, P and Le Du, D and Melchior, J.Cl and Sehouane, R and Troisvallets, D and Blanc, M and Boccon-Gibod, I and Bosseray, A and Brion, J.P and Durand, F and Leclercq, P and Marion, F and Pavese, P and Brottier-Mancini, E and Faba, L and Roncato-Saberan, M and Bollengier-Stragier, O and Esnault, J.L and Leautez-Nainville, S and Perré, P and Froguel, E and Nguessan, M and Simon, P and Colardelle, P and ... and ANRS VESPA2 Study Grp and ANRS-VESPA2 Study Group
PLoS ONE, ISSN 1932-6203, 02/2017, Volume 12, Issue 2, p. e0171645
Background Suicide risk is high among people living with HIV (PLHIV). This study aimed to identify major correlates of suicide risk in a representative sample... 
ALCOHOL-USE | COMPLETED SUICIDE | BEHAVIOR | MULTIDISCIPLINARY SCIENCES | AIDS | SMOKING | INFECTION | USE DISORDERS | IDEATION | HEPATITIS-C | ASSOCIATION | Multivariate Analysis | France - epidemiology | Cross-Sectional Studies | Comorbidity | HIV Infections - epidemiology | HIV Infections - virology | Humans | Middle Aged | Risk Factors | Suicide, Attempted - statistics & numerical data | Male | Suicide - statistics & numerical data | Young Adult | Regression Analysis | Health Surveys - methods | Hepatitis C - epidemiology | Adolescent | Adult | Female | HIV Infections - drug therapy | Poisson Distribution | Health Surveys - statistics & numerical data | Psychological aspects | Surveys | Suicidal behavior | HIV patients | Social aspects | Health aspects | Risk factors | Alcohol | Infections | Suicide | Epidemiology | Subgroups | Homelessness | Mens health | Sexually transmitted diseases | Demographics | Immunology | Social interactions | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Suicides & suicide attempts | Drug use | Public health | Health risks | Studies | Discrimination | Hospitals | Disease transmission | Correlation analysis | Social conditions | Smoking | Life Sciences | Human health and pathology | Acquired immune deficiency syndrome | HIV | Human immunodeficiency virus
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 06/2017, Volume 17, Issue 1
Treatment comprised simeprevir 150 mg once daily (QD) plus PegIFN[alpha]-2a/RBV for 12 weeks followed by PegIFN[alpha]-2a/RBV for 12 or 36 weeks (using... 
Prevention | Care and treatment | Dosage and administration | Research | Hepatitis C virus | Ribavirin
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.